naproxen has been researched along with imiquimod in 3 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (imiquimod) | Trials (imiquimod) | Recent Studies (post-2010) (imiquimod) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 3,264 | 284 | 1,963 |
Protein | Taxonomy | naproxen (IC50) | imiquimod (IC50) |
---|---|---|---|
Histamine H2 receptor | Homo sapiens (human) | 1.506 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.621 | |
Adenosine receptor A2a | Homo sapiens (human) | 5.32 | |
7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | 0.646 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Das, MR; Dastidar, P; Deb, J; Jana, SS; Majumder, J | 1 |
3 other study(ies) available for naproxen and imiquimod
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Designing a simple organic salt-based supramolecular topical gel capable of displaying in vivo self-delivery application.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Carriers; Drug Design; Gels; Imiquimod; Inflammation; Male; Mice; Naproxen; Peptides; Salts | 2014 |